Clik here to view.
患者安全运动基金会预告以医护工作者安全为中心的世界患者安全日活动
加州尔湾 (美国商业资讯)–患者安全运动基金会(Patient Safety Movement Foundation,...
View ArticleClik here to view.
Gelesis Announces Partnership for Commercial Launch of Plenity® in China
BOSTON Gelesis, a biotechnology company developing a novel hydrogel platform technology to treat overweight, obesity and other chronic metabolic diseases, today announced a partnership with China...
View ArticleClik here to view.
日本膳食补剂Nichi Glucan是用于Covid-19的免疫增强剂
东京 (美国商业资讯)–《免疫学前沿杂志》(Frontiers in Immunology Journal)推荐的临床研究验证显示，一种用黑酵母Aureobasidium Pullulans生产的独特的基于Beta...
View ArticleClik here to view.
三叶草生物制药完成新冠疫苗I期临床试验首批志愿者接种
澳大利亚珀斯和成都 (美国商业资讯)–三叶草生物制药今天宣布已完成其在研新冠病毒蛋白亚基疫苗候选物 “S-三聚体” 人体1期临床试验首批健康志愿者的接种。三叶草生物“S-三聚体”...
View ArticleClik here to view.
Clover Biopharmaceuticals Initiates Phase 1 Clinical Trial for COVID-19...
PERTH, Australia & CHENGDU, China Clover Biopharmaceuticals today announced that the first participants have been dosed in the Phase 1 first-in-human study evaluating the company’s COVID-19...
View ArticleClik here to view.
Clik here to view.
Clik here to view.
Clik here to view.
Clik here to view.
亚洲公益事业研究中心行善指数筹划全球在Covid-19后的前进道路
香港 (美国商业资讯)–亚洲公益事业研究中心(The Centre for Asian Philanthropy and Society, CAPS)今天发布了第二版行善指数(Doing Good Index,...
View ArticleClik here to view.
アジア・フィランソロピー・アンド・ソサエティ・センターのDoing Good Index（良き行い指数）がCovid-19後の世界で進むべき道を示す
香港 （ビジネスワイヤ） — アジア・フィランソロピー・アンド・ソサエティ・センター（CAPS）は本日、「Doing Good...
View ArticleClik here to view.
Merck’s KEYTRUDA® (pembrolizumab) Approved in China for Second-Line Treatment...
KENILWORTH, N.J. Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck’s anti-PD-1 therapy, has been approved by the National Medical Products...
View ArticleClik here to view.
Nanox Enters Asia Pacific: Signs Strategic Agreement With Golden Vine...
NEVE ILAN, Israel & TAIPEI, Taiwan NANO-X IMAGING LTD (www.nanox.vision) (“Nanox” or the “Company”), an innovative medical imaging technology company, announces it has signed an exclusive...
View ArticleClik here to view.
Apyx Medical Corporation Announces Regulatory Clearance to Market and Sell...
CLEARWATER, Fla. Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the...
View ArticleClik here to view.
沃特世推出全新Arc HPLC高效液相色谱，助力实验室达成质量和生产目标
美国马萨诸塞州米尔福德市，即时发布 沃特世公司（纽约证券交易所代码：WAT）近日正式推出一款全新高效液相色谱系统（HPLC）——Waters Arc HPLC。该系统专为制药、食品、科研和材料领域的常规检测而打造，主要用于质量控制实验室的小分子药物批次放行检测。除此之外，沃特世还将发售搭载SecureSync的Waters Empower BC...
View ArticleClik here to view.
Waters Introduces the New Arc High-Performance Liquid Chromatograph to Help...
MILFORD, Mass. Waters Corporation (NYSE:WAT) today introduced the Waters™ Arc™ HPLC System, a new high-performance liquid chromatograph (HPLC) for routine testing in the pharmaceutical, food,...
View ArticleClik here to view.
Sengenics Launches ImmuSAFE COVID+, the World’s First High-Throughput,...
SINGAPORE Sengenics, the Functional Proteomics Company, today announced the launch of ImmuSAFE™ COVID+, a multi-antigen, multi-domain, fully quantitative serology test. ImmuSAFE™ enables the...
View ArticleClik here to view.
ウォーターズはラボの品質と生産目標を達成することに役立つ新型の高速液体クロマトグラフ「Arc HPLC」を発表
マサチューセッツ州ミルフォード （ビジネスワイヤ） — ウォーターズコーポレーション (NYSE:WAT) は本日、医薬品、食品、学術研究、材料市場でのルーチン分析のための新しい高速液体クロマトグラフィー (HPLC) である Waters™ Arc™ HPLC...
View ArticleClik here to view.
南丰生命科技主导ENGRAIL THERAPEUTICS A轮融资
北京 Engrail Therapeutics™（Engrail）（公司）日前宣布完成3200万美元的A轮融资。本轮融资由南丰集团的全球生命科技投资平台南丰生命科技（NFLS）主导。该公司计划利用融资所得支持其第一个产品ENX-101的临床开发，ENX-101是一种GABA A亚型选择性受体调节剂。...
View ArticleClik here to view.
DIH任命Vaseem Mahboob为执行副总裁兼首席财务官
马萨诸塞州诺韦尔 (美国商业资讯)–以通过创新和整合来转变康复护理模式为愿景的全球领先机器人和虚拟现实(VR)技术提供商DIH今天宣布，其已任命Vaseem Mahboob为公司执行副总裁兼首席财务官(CFO)，自2020年7月9日起生效。Mahboob先生还将担任DIH公司执行委员会成员。 DIH创始人、董事长兼首席执行官Jason...
View Article